Skip to content
Sweat Explained

Research

Red Flags for Secondary Hyperhidrosis: When Sweating Signals Something Else

Most excessive sweating is primary focal hyperhidrosis: it starts in childhood or adolescence, affects specific body areas symmetrically, and stops during sleep. But a minority of cases are secondary, meaning the sweating is a symptom of something else, from medications and menopause to hyperthyroidism, infection, or, uncommonly, malignancy. Clinicians distinguish the two using a small set of well-described red flags: onset after age 25, generalized or asymmetric distribution, persistence during sleep ("night sweats"), a lack of family history, and accompanying symptoms such as unintentional weight loss or fever. This page summarizes what the peer-reviewed literature says about those red flags. It is educational; it is not diagnostic or medical advice, and any concerning symptom should be discussed with a clinician.

By the Sweat Explained Editorial Team · Published 2026-07-19 · Last reviewed 2026-07-19 · Educational information, not medical advice.

Key statistics at a glance

  • ~93%

    of patients with hyperhidrosis have the primary form; the remaining minority are secondary

    Nawrocki & Cha 2019 JAAD CME

  • < 25 years

    typical age of onset for primary focal hyperhidrosis; onset after 25 is a red flag for a secondary cause

    Hornberger 2004 consensus criteria

  • 4 of 6

    diagnostic criteria give a positive predictive value of 0.99 for primary hyperhidrosis (negative predictive value 0.85)

    AFP 2018 review of Hornberger criteria

  • generalized or asymmetric

    distribution favors a secondary cause; primary hyperhidrosis is focal and bilateral

    Nawrocki 2019; Callejas 2010

  • > 10% body weight

    unintentional weight loss over 6 months is a recognized red flag when paired with night sweats

    Ann Arbor B-symptom criteria; AFP 2020

Why the distinction matters

Primary focal hyperhidrosis is treated in the dermatology or hyperhidrosis clinic; secondary hyperhidrosis is treated by finding and addressing the underlying cause. Missing a secondary cause can mean missing the actual illness. Distinguishing the two is therefore not academic; it changes what a clinician looks for and what tests, if any, are ordered.

The clearest published framework is the multi-specialty consensus of Hornberger and colleagues (2004), which defines primary focal hyperhidrosis positively (six symptom features, at least two required) and lists specific secondary causes to exclude. A 2018 American Family Physician review noted that requiring four of the six positive features gives a positive predictive value of 0.99 and a negative predictive value of 0.85 for primary hyperhidrosis. If several of those features are missing, or the picture actively contradicts them, secondary causes come to the front of the differential.

Primary versus secondary: what the literature says

The clinical features most consistently used to separate the two, drawn from the Hornberger criteria and subsequent reviews (Nawrocki 2019; Callejas 2010; NICE CKS).

Characteristic features of primary focal versus secondary hyperhidrosis
FeaturePrimary focalSecondary
Age at onsetTypically < 25 years, often childhood or adolescenceAny age, more commonly after 25 (often 4th decade or later)
DistributionFocal and bilaterally symmetric (axillae, palms, soles, craniofacial)Generalized, or focal but asymmetric/unilateral
Sweating during sleepUsually stops during sleepOften continues during sleep (night sweats)
Family historyFrequently positiveUsually absent
Associated symptomsNone (dry sweating, otherwise well)May include weight loss, fever, tremor, palpitations, adenopathy, or drug/menopause context
Response to focal treatmentPredictable (antiperspirants, iontophoresis, botulinum toxin)Depends on the underlying cause; focal treatment often insufficient

These are population-level tendencies, not rules for any one person. Overlap exists and a clinician should evaluate the whole picture.

Recognized red flags

The features most consistently described in reviews as reasons to look for a secondary cause:

  • Onset after age 25. Primary focal hyperhidrosis is a childhood-onset trait. New-onset excessive sweating in adulthood, especially after age 40, has a higher prior probability of a medication effect, endocrine disorder, or systemic illness.
  • Generalized sweating. Sweating that affects the whole body rather than sticking to one or two focal sites is described across reviews (Nawrocki 2019; Callejas 2010) as more suggestive of a secondary cause such as thyroid disease, diabetes-related hypoglycemia, menopause, medication effect, or infection.
  • Asymmetric or unilateral sweating. Primary focal hyperhidrosis is bilateral. Unilateral or clearly asymmetric sweating can point to a neurological cause (compression along the sympathetic chain, cervical rib, Frey's syndrome after parotid surgery) or, uncommonly, intrathoracic pathology.
  • Sweating that persists during sleep. Primary focal sweating typically stops when the person sleeps. Sweating that continues in sleep ("night sweats") is a defining feature of many secondary causes, including menopause, medication effect, infection, and, occasionally, lymphoma or tuberculosis.
  • No family history. A positive family history is a supportive feature of primary focal hyperhidrosis. Its absence is not diagnostic on its own but reduces the likelihood of the primary pattern when combined with other red flags.
  • Accompanying systemic symptoms. Unintentional weight loss, fever, tremor, palpitations, heat or cold intolerance, lymphadenopathy, or drenching night sweats with any of these should trigger a workup for infection, thyroid disease, or malignancy.

The special case of night sweats

"Night sweats" are worth their own line. In classic hematology, drenching night sweats, fever above 38 °C, and unintentional weight loss (> 10% of body weight over 6 months) are the Ann Arbor B-symptoms associated with staging in Hodgkin lymphoma. Isolated night sweats without other features are far more often benign (menopause, medications, sleep apnea, reflux) than caused by malignancy, but any of the classic B-symptom combinations warrants a clinician visit and, per primary-care reviews, an initial workup that may include a complete blood count, thyroid-stimulating hormone, HIV, tuberculosis screening, C-reactive protein, and chest imaging.

The take-home from primary-care research is not "night sweats mean cancer." It is: night sweats behave differently from primary focal hyperhidrosis, so they should not be filed under the same heading, and if they are drenching, persistent, or accompanied by fever, weight loss, or lumps, they should be evaluated.

Common secondary causes to consider

Reviews (Nawrocki & Cha 2019; Menon 2024; NICE CKS) group secondary causes into a small number of categories:

  • Endocrine: hyperthyroidism, diabetes-related hypoglycemia, menopause, pheochromocytoma, carcinoid syndrome, acromegaly.
  • Medications: selective serotonin and serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, opioids, cholinergic agents, certain hormonal therapies.
  • Infection: tuberculosis, HIV, endocarditis, brucellosis, other chronic infections.
  • Malignancy: lymphoma (classic B-symptoms), some solid tumors; uncommon but important.
  • Neurological: post-stroke, autonomic neuropathy, Frey's syndrome after parotid surgery, compensatory sweating after sympathectomy, spinal cord injury.
  • Substance use: alcohol use and withdrawal, opioid withdrawal, stimulant use.
  • Physiological or reproductive: pregnancy, perimenopause and menopause, and normal fever.

How clinicians work through the red flags

Guidelines emphasize that laboratory testing is not required when the presentation is clearly primary focal hyperhidrosis. When red flags are present, initial workup in primary care is usually inexpensive and targeted, guided by the specific features. Reviews (AFP 2018 and 2020; NICE CKS) list first-tier tests such as thyroid-stimulating hormone, fasting glucose, complete blood count, C-reactive protein, HIV test, tuberculosis screening, and a chest radiograph, plus a medication review. Further imaging or referral is guided by what those tests and the physical exam suggest.

The purpose of enumerating red flags is not to alarm every person with sweating, but to draw a clean line: focal, childhood-onset, symmetric, sleep-sparing, family-associated sweating is very likely primary hyperhidrosis; a pattern that breaks those rules deserves a second look.

Methodology and limitations

This page synthesizes the Hornberger 2004 multi-specialty consensus on primary focal hyperhidrosis (J Am Acad Dermatol 51:274-286), the Nawrocki & Cha 2019 comprehensive review in JAAD (Part I, etiology and clinical work-up), the 2018 American Family Physician review (Hyperhidrosis: Management Options), the 2020 AFP review on persistent night sweats, the Menon et al. 2024 review on secondary hyperhidrosis (Cureus), the NICE CKS hyperhidrosis topic, and the 2022 review by Skroza et al. (Postepy Dermatol Alergol). Each specific claim (~93% primary; 4-of-6 criteria PPV 0.99 / NPV 0.85; > 10% weight loss over 6 months as Ann Arbor B-symptom; onset < 25 as a positive Hornberger criterion) was traced to those sources.

Limitations: red flags are risk stratifiers, not diagnoses. Primary and secondary hyperhidrosis can overlap; some patients with a systemic condition also have long-standing focal hyperhidrosis. Numeric predictive values (PPV 0.99, NPV 0.85) come from applying the Hornberger criteria in the specific referral populations studied and may not generalize to every clinic. Night-sweats prevalence and cause distributions in primary care are described qualitatively rather than as a fixed cause-yield percentage, because the literature does not support a single reliable breakdown. Nothing on this page is medical advice; anyone with concerning symptoms should see a clinician.

Frequently asked questions

What is the difference between primary and secondary hyperhidrosis?
Primary focal hyperhidrosis is a sweating disorder itself: usually childhood-onset, focal (axillae, palms, soles, or craniofacial), bilateral and symmetric, sleep-sparing, and often familial. Secondary hyperhidrosis is excessive sweating caused by another condition, medication, or physiological state, and typically presents differently (generalized, asymmetric, or continuing during sleep).
What are the main red flags for a secondary cause?
The most consistently cited red flags are onset after age 25, generalized or asymmetric distribution, sweating that persists during sleep, no family history, and accompanying symptoms such as unintentional weight loss, fever, tremor, palpitations, or lymphadenopathy.
Is late-onset sweating always secondary?
Not always. Primary focal hyperhidrosis can occasionally begin later in life, and reviews note that if other Hornberger criteria are met, primary hyperhidrosis remains possible in a person whose sweating started after age 25. But later onset raises the prior probability of a secondary cause, so clinicians look harder for one.
Do night sweats mean cancer or infection?
Usually not. Most night sweats seen in primary care are related to menopause, medications, sleep problems, or benign conditions. Drenching night sweats combined with fever above 38 °C and unintentional weight loss greater than 10% of body weight over 6 months (the Ann Arbor B-symptoms) should be evaluated, since they can accompany lymphoma, tuberculosis, or other serious conditions.
What tests are usually done if a secondary cause is suspected?
Guidelines suggest a targeted history and physical exam, a medication review, and first-tier tests that may include thyroid-stimulating hormone, fasting glucose, complete blood count, C-reactive protein, HIV testing, tuberculosis screening, and a chest radiograph. Further testing depends on the specific findings.
When should someone see a clinician about sweating?
Any sweating that starts suddenly, is asymmetric, continues through sleep, is generalized, or comes with weight loss, fever, palpitations, tremor, or lymph node swelling is worth a clinician visit. Even without those features, primary focal hyperhidrosis is a treatable medical condition and can be discussed with a doctor.

Sources

Primary peer-reviewed studies and official sources first, then reviews and institutional framing (secondary).

  1. Hornberger J, Grimes K, Naumann M, et al.; Multi-Specialty Working Group on the Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol. 2004;51(2):274-286. Full text
  2. Nawrocki S, Cha J. The etiology, diagnosis, and management of hyperhidrosis: a comprehensive review. Part I: etiology and clinical work-up. J Am Acad Dermatol. 2019;81(3):657-666. PubMed
  3. McConaghy JR, Fosselman D. Hyperhidrosis: management options. Am Fam Physician. 2018;97(11):729-734. AFP
  4. Smetana GW. Persistent night sweats: diagnostic evaluation. Am Fam Physician. 2020;102(7):427-433. (secondary) AFP
  5. Menon B, Malik A, Whitley MJ, et al. A review of the etiologies and key clinical features of secondary hyperhidrosis. Cureus. 2024;16(10):e72525. (secondary) PubMed
  6. Skroza N, Bernardini N, La Torre G, et al. Hyperhidrosis: disease aetiology, classification and management in the light of modern treatment modalities. Postepy Dermatol Alergol. 2022;39(2):251-257. (secondary) Full text
  7. National Institute for Health and Care Excellence (NICE) CKS. Hyperhidrosis: how should I assess a person with excessive sweating? NICE Clinical Knowledge Summaries topic. (secondary) NICE CKS
  8. Cheah CY, Wirth A, Seymour JF. The diagnosis and management of suspected lymphoma in general practice (B-symptoms). Br J Gen Pract. 2023 (open-access review). (secondary) Full text

How to cite this page

Sweat Explained. Red Flags for Secondary Hyperhidrosis: When Sweating Signals Something Else. Published 2026-07-19; last reviewed 2026-07-19. Available at: https://sweatexplained.com/research/secondary-hyperhidrosis-red-flags

Please cite the original studies for the underlying figures. Journalists are welcome to link to this page; the charts are original renderings of the cited data.